420 related articles for article (PubMed ID: 18844342)
21. New steroidal 7-azaindole platinum(II) antitumor complexes.
Zamora A; Rodríguez V; Cutillas N; Yellol GS; Espinosa A; Samper KG; Capdevila M; Palacios O; Ruiz J
J Inorg Biochem; 2013 Nov; 128():48-56. PubMed ID: 23932925
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and anticancer activity of [2-hydroxy-1,3-diaminopropane-kappa 2N,N'] platinum(II) complexes.
Liu W; Chen X; Xie M; Lou L; Ye Q; Yu Y; Hou S
J Inorg Biochem; 2008 Oct; 102(10):1942-6. PubMed ID: 18707762
[TBL] [Abstract][Full Text] [Related]
23. Anticancer C,N-cycloplatinated(II) complexes containing fluorinated phosphine ligands: synthesis, structural characterization, and biological activity.
Cutillas N; Martínez A; Yellol GS; Rodríguez V; Zamora A; Pedreño M; Donaire A; Janiak C; Ruiz J
Inorg Chem; 2013 Dec; 52(23):13529-35. PubMed ID: 24229419
[TBL] [Abstract][Full Text] [Related]
24. Synthesis, characterisation, activities, cell uptake and DNA binding of [[trans-PtCl(NH3)2] [mu-(H2N(CH2)6NH2)] [trans-PdCl(NH3)2](NO3)Cl.
Huq F; Daghriri H; Yu JQ; Tayyem H; Beale P; Zhang M
Eur J Med Chem; 2004 Nov; 39(11):947-58. PubMed ID: 15501544
[TBL] [Abstract][Full Text] [Related]
25. Synthesis, characterisation, activities, cell uptake and DNA binding of a trinuclear complex: [[trans-PtCl(NH3)]2mu-[trans-Pd(NH3)(2-hydroxypyridine)-(H2)N(CH2)6NH2)2]Cl4.
Cheng H; Huq F; Beale P; Fisher K
Eur J Med Chem; 2006 Jul; 41(7):896-903. PubMed ID: 16730394
[TBL] [Abstract][Full Text] [Related]
26. Synthesis of trans-bis-(2-hydroxypyridine)dichloroplatinum(II) and its activity in human ovarian tumour models.
Deqnah N; Yu JQ; Beale P; Fisher K; Huq F
Anticancer Res; 2012 Jan; 32(1):135-40. PubMed ID: 22213298
[TBL] [Abstract][Full Text] [Related]
27. Platinum(II) compounds with chelating ligands based on pyridine and pyrimidine: synthesis, characterizations, DFT calculations, cytotoxic assays and binding to a DNA model base.
Roy S; Westmaas JA; Buda F; Reedijk J
J Inorg Biochem; 2009 Sep; 103(9):1278-87. PubMed ID: 19656572
[TBL] [Abstract][Full Text] [Related]
28. New isomeric azine-bridged dinuclear platinum(II) complexes circumvent cross-resistance to cisplatin.
Komeda S; Kalayda GV; Lutz M; Spek AL; Yamanaka Y; Sato T; Chikuma M; Reedijk J
J Med Chem; 2003 Mar; 46(7):1210-9. PubMed ID: 12646031
[TBL] [Abstract][Full Text] [Related]
29. Structure and dynamics of methyl cis-3,4-diamino-2,3,4,6-tetradeoxy-alpha-L-lyxo-hexopyranoside complexes with PtCl(2) and PdCl(2), by (1)H, (2)H, (13)C, (15)N and (195)Pt NMR spectroscopy in DMSO, CD(3)CN and H(2)O.
Bednarek E; Sitkowski J; Kawecki R; Kozerski L; Bocian W; Pazderski L; Priebe W
Dalton Trans; 2008 Aug; (31):4129-37. PubMed ID: 18688431
[TBL] [Abstract][Full Text] [Related]
30. Synthesis, structures and in vitro cytotoxicity of some platinum(II) complexes containing thiocarbamate esters.
Dolfen D; Schottler K; Valiahdi SM; Jakupec MA; Keppler BK; Tiekink ER; Mohr F
J Inorg Biochem; 2008 Dec; 102(12):2067-71. PubMed ID: 18707761
[TBL] [Abstract][Full Text] [Related]
31. Preparation of antitumor oxaliplatin/cisplatin docking dinuclear platinum complex.
Noji M; Kizu R; Takeda Y; Akiyama N; Yoshizaki I; Eriguchi M; Kidani Y
Biomed Pharmacother; 2005 Jun; 59(5):224-9. PubMed ID: 15919175
[TBL] [Abstract][Full Text] [Related]
32. Platinum(II) oxalato complexes with adenine-based carrier ligands showing significant in vitro antitumor activity.
Starha P; Trávnícek Z; Popa I
J Inorg Biochem; 2010 Jun; 104(6):639-47. PubMed ID: 20304500
[TBL] [Abstract][Full Text] [Related]
33. Studies on the activity of two Trans-planaramine platinum(II) complexes coded as DH4 and DH5 in human ovarian tumour models.
Deqnah N; Yu JQ; Beale P; Huq F
Anticancer Res; 2012 Dec; 32(12):5331-6. PubMed ID: 23225434
[TBL] [Abstract][Full Text] [Related]
34. Application of fluorescence microscopy for investigation of cellular distribution of dinuclear platinum anticancer drugs.
Kalayda GV; Zhang G; Abraham T; Tanke HJ; Reedijk J
J Med Chem; 2005 Aug; 48(16):5191-202. PubMed ID: 16078838
[TBL] [Abstract][Full Text] [Related]
35. Palladium and platinum 3,5-diacetyl-1,2,4-triazol bis(thiosemicarbazones): chemistry, cytotoxic activity and structure-activity relationships.
Matesanz AI; Souza P
J Inorg Biochem; 2007 Feb; 101(2):245-53. PubMed ID: 17097146
[TBL] [Abstract][Full Text] [Related]
36. Reactivity of ammonia ligands of the antitumor agent cisplatin: a unique dodecanuclear Pt4,Pd4,Ag4 platform for four cytosine model nucleobases.
Kampf G; Sanz Miguel PJ; Morell Cerdà M; Willermann M; Schneider A; Lippert B
Chemistry; 2008; 14(23):6882-91. PubMed ID: 18576415
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and cytotoxicity of platinum(II) complexes of a physiologically active carrier histamine.
Chen XZ; Ye QS; Lou LG; Xie MJ; Liu WP; Yu Y; Hou SQ
Arch Pharm (Weinheim); 2008 Feb; 341(2):132-6. PubMed ID: 18186542
[TBL] [Abstract][Full Text] [Related]
38. Synthesis of antitumor azolato-bridged dinuclear platinum(ii) complexes with in vivo antitumor efficacy and unique in vitro cytotoxicity profiles.
Komeda S; Takayama H; Suzuki T; Odani A; Yamori T; Chikuma M
Metallomics; 2013 May; 5(5):461-8. PubMed ID: 23608770
[TBL] [Abstract][Full Text] [Related]
39. New 7-azaindole palladium and platinum complexes: crystal structures and theoretical calculations. In vitro anticancer activity of the platinum compounds.
Ruiz J; Rodríguez V; de Haro C; Espinosa A; Pérez J; Janiak C
Dalton Trans; 2010 Apr; 39(13):3290-301. PubMed ID: 20449459
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and antitumour activity of a new trinuclear platinum compound [{cis-PtCl(NH3)2μ {trans-Pt(3-hydroxypyridine)2H2N(CH2)5NH2)2}] Cl4 in human ovarian cancer cells.
Hamad SA; Beale P; Yu JQ; Huq F
Anticancer Res; 2014 Apr; 34(4):1923-9. PubMed ID: 24692727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
